0 XP   0   0   0

Medipharm Labs Corp
Buy or Sell?

Welcome Invester! I guess you are interested in Medipharm Labs Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's start. I'm going to help you getting a better view of Medipharm Labs Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Medipharm Labs Corp even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Medipharm Labs Corp is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Medipharm Labs Corp. The closing price on 2022-09-29 was $0.0514 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Medipharm Labs Corp Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Medipharm Labs Corp.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Medipharm Labs Corp earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Medipharm Labs Corp to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Net Profit Margin of -218.5% means that $-2.19 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Medipharm Labs Corp:

  • The MRQ is -206.0%. The company is making a huge loss. -2
  • The TTM is -218.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-206.0%TTM-218.5%+12.5%
TTM-218.5%YOY-324.7%+106.1%
TTM-218.5%5Y-140.2%-78.3%
5Y-140.2%10Y-140.2%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-206.0%0.8%-206.8%
TTM-218.5%1.0%-219.5%
YOY-324.7%1.7%-326.4%
5Y-140.2%0.6%-140.8%
10Y-140.2%1.2%-141.4%
1.1.2. Return on Assets

Shows how efficient Medipharm Labs Corp is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Medipharm Labs Corp to the Drug Manufacturers-Specialty & Generic industry mean.
  • -12.5% Return on Assets means that Medipharm Labs Corp generated $-0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Medipharm Labs Corp:

  • The MRQ is -11.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -12.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.3%TTM-12.5%+1.1%
TTM-12.5%YOY-13.9%+1.4%
TTM-12.5%5Y-8.1%-4.3%
5Y-8.1%10Y-8.1%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.3%0.2%-11.5%
TTM-12.5%0.2%-12.7%
YOY-13.9%0.1%-14.0%
5Y-8.1%-0.1%-8.0%
10Y-8.1%0.2%-8.3%
1.1.3. Return on Equity

Shows how efficient Medipharm Labs Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Medipharm Labs Corp to the Drug Manufacturers-Specialty & Generic industry mean.
  • -13.1% Return on Equity means the company generated $-0.13 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Medipharm Labs Corp:

  • The MRQ is -13.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -14.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-13.1%TTM-14.1%+1.0%
TTM-14.1%YOY-19.0%+5.0%
TTM-14.1%5Y-10.4%-3.7%
5Y-10.4%10Y-10.4%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.1%0.8%-13.9%
TTM-14.1%0.6%-14.7%
YOY-19.0%0.6%-19.6%
5Y-10.4%0.1%-10.5%
10Y-10.4%0.5%-10.9%

1.2. Operating Efficiency of Medipharm Labs Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Medipharm Labs Corp is operating .

  • Measures how much profit Medipharm Labs Corp makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Medipharm Labs Corp to the Drug Manufacturers-Specialty & Generic industry mean.
  • An Operating Margin of -156.1% means the company generated $-1.56  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Medipharm Labs Corp:

  • The MRQ is -156.1%. The company is operating very inefficient. -2
  • The TTM is -190.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-156.1%TTM-190.6%+34.5%
TTM-190.6%YOY-282.5%+91.9%
TTM-190.6%5Y-122.0%-68.6%
5Y-122.0%10Y-122.0%0.0%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-156.1%3.5%-159.6%
TTM-190.6%2.3%-192.9%
YOY-282.5%3.9%-286.4%
5Y-122.0%3.5%-125.5%
10Y-122.0%1.9%-123.9%
1.2.2. Operating Ratio

Measures how efficient Medipharm Labs Corp is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 420.1% means that the operating costs are $4.20for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Medipharm Labs Corp:

  • The MRQ is 4.201. The company is inefficient in keeping operating costs low. -1
  • The TTM is 4.311. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ4.201TTM4.311-0.110
TTM4.311YOY6.884-2.573
TTM4.3115Y3.525+0.786
5Y3.52510Y3.5250.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ4.2011.483+2.718
TTM4.3111.435+2.876
YOY6.8841.382+5.502
5Y3.5251.363+2.162
10Y3.5251.160+2.365

1.3. Liquidity of Medipharm Labs Corp.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Medipharm Labs Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 523.1% means the company has $5.23 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Medipharm Labs Corp:

  • The MRQ is 5.231. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.325. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.231TTM6.325-1.094
TTM6.325YOY5.260+1.065
TTM6.3255Y4.322+2.003
5Y4.32210Y4.3220.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ5.2311.887+3.344
TTM6.3251.900+4.425
YOY5.2602.104+3.156
5Y4.3222.156+2.166
10Y4.3221.840+2.482
1.3.2. Quick Ratio

Measures if Medipharm Labs Corp is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean)
  • A Quick Ratio of 142.5% means the company can pay off $1.42 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Medipharm Labs Corp:

  • The MRQ is 1.425. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.763. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.425TTM1.763-0.338
TTM1.763YOY1.812-0.050
TTM1.7635Y1.165+0.597
5Y1.16510Y1.1650.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4250.638+0.787
TTM1.7630.784+0.979
YOY1.8120.809+1.003
5Y1.1650.838+0.327
10Y1.1650.834+0.331

1.4. Solvency of Medipharm Labs Corp.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Medipharm Labs Corp assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Debt to Asset Ratio of 0.13 means that Medipharm Labs Corp assets are financed with 13.5% credit (debt) and the remaining percentage (100% - 13.5%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Medipharm Labs Corp:

  • The MRQ is 0.135. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.116. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.135TTM0.116+0.018
TTM0.116YOY0.231-0.114
TTM0.1165Y0.235-0.118
5Y0.23510Y0.2350.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1350.429-0.294
TTM0.1160.412-0.296
YOY0.2310.391-0.160
5Y0.2350.390-0.155
10Y0.2350.396-0.161
1.4.2. Debt to Equity Ratio

Measures if Medipharm Labs Corp is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Debt to Equity ratio of 15.6% means that company has $0.16 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Medipharm Labs Corp:

  • The MRQ is 0.156. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.132. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.156TTM0.132+0.023
TTM0.132YOY0.318-0.185
TTM0.1325Y0.339-0.207
5Y0.33910Y0.3390.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1560.695-0.539
TTM0.1320.677-0.545
YOY0.3180.624-0.306
5Y0.3390.678-0.339
10Y0.3390.689-0.350

2. Market Valuation of Medipharm Labs Corp

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Medipharm Labs Corp.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of -0.33 means the investor is paying $-0.33 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Medipharm Labs Corp:

  • The EOD is -0.307. Company is losing money. -2
  • The MRQ is -0.335. Company is losing money. -2
  • The TTM is -0.624. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-0.307MRQ-0.335+0.028
MRQ-0.335TTM-0.624+0.289
TTM-0.624YOY-1.273+0.650
TTM-0.6245Y-11.685+11.062
5Y-11.68510Y-11.6850.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD-0.3070.342-0.649
MRQ-0.3350.416-0.751
TTM-0.6241.360-1.984
YOY-1.2733.493-4.766
5Y-11.6856.176-17.861
10Y-11.6856.811-18.496
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Medipharm Labs Corp.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Medipharm Labs Corp:

  • The MRQ is 0.006. Very good. +2
  • The TTM is -0.002. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ0.006TTM-0.002+0.008
TTM-0.002YOY-0.0020.000
TTM-0.0025Y-0.006+0.004
5Y-0.00610Y-0.0060.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0060.003+0.003
TTM-0.0020.020-0.022
YOY-0.0020.032-0.034
5Y-0.0060.026-0.032
10Y-0.0060.028-0.034

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Medipharm Labs Corp is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A PB ratio of 0.23 means the investor is paying $0.23 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Medipharm Labs Corp:

  • The EOD is 0.207. Very good. +2
  • The MRQ is 0.226. Very good. +2
  • The TTM is 0.440. Very good. +2
Trends
Current periodCompared to+/- 
EOD0.207MRQ0.226-0.019
MRQ0.226TTM0.440-0.214
TTM0.440YOY0.846-0.406
TTM0.4405Y0.611-0.170
5Y0.61110Y0.6110.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD0.2071.442-1.235
MRQ0.2261.617-1.391
TTM0.4402.042-1.602
YOY0.8462.274-1.428
5Y0.6112.006-1.395
10Y0.6111.538-0.927

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Medipharm Labs Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Gains Per Share---0.030-0.042+39%-0.111+270%0.023-233%0.023-233%
Book Value Per Share--0.2480.305-19%0.532-53%0.358-31%0.358-31%
Current Ratio--5.2316.325-17%5.260-1%4.322+21%4.322+21%
Debt To Asset Ratio--0.1350.116+16%0.231-42%0.235-43%0.235-43%
Debt To Equity Ratio--0.1560.132+18%0.318-51%0.339-54%0.339-54%
Dividend Per Share----0%-0%-0%-0%
Eps---0.033-0.042+29%-0.101+211%-0.044+37%-0.044+37%
Gains Per Share---0.030-0.042+39%-0.111+270%0.023-233%0.023-233%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin---2.060-2.185+6%-3.247+58%-1.402-32%-1.402-32%
Operating Margin---1.561-1.906+22%-2.825+81%-1.220-22%-1.220-22%
Operating Ratio--4.2014.311-3%6.884-39%3.525+19%3.525+19%
Pb Ratio0.207-9%0.2260.440-49%0.846-73%0.611-63%0.611-63%
Pe Ratio-0.307+8%-0.335-0.624+86%-1.273+280%-11.685+3389%-11.685+3389%
Peg Ratio--0.006-0.002+132%-0.002+132%-0.006+206%-0.006+206%
Price Per Share0.051-9%0.0560.138-59%0.451-88%1.051-95%1.051-95%
Quick Ratio--1.4251.763-19%1.812-21%1.165+22%1.165+22%
Return On Assets---0.113-0.125+10%-0.139+22%-0.081-28%-0.081-28%
Return On Equity---0.131-0.141+7%-0.190+45%-0.104-21%-0.104-21%
 EOD+2 -1MRQTTM+10 -7YOY+12 -55Y+7 -1010Y+7 -10

3.2. Fundamental Score

Let's check the fundamental score of Medipharm Labs Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.307
Price to Book Ratio (EOD)Between0-10.207
Net Profit Margin (MRQ)Greater than0-2.060
Operating Margin (MRQ)Greater than0-1.561
Quick Ratio (MRQ)Greater than11.425
Current Ratio (MRQ)Greater than15.231
Debt to Asset Ratio (MRQ)Less than10.135
Debt to Equity Ratio (MRQ)Less than10.156
Return on Equity (MRQ)Greater than0.15-0.131
Return on Assets (MRQ)Greater than0.05-0.113
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Medipharm Labs Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.140
Ma 20Greater thanMa 500.056
Ma 50Greater thanMa 1000.060
Ma 100Greater thanMa 2000.060
OpenGreater thanClose0.056
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets79,241
Total Liabilities10,674
Total Stockholder Equity68,567
 As reported
Total Liabilities 10,674
Total Stockholder Equity+ 68,567
Total Assets = 79,241

Assets

Total Assets79,241
Total Current Assets54,309
Long-term Assets54,309
Total Current Assets
Cash And Cash Equivalents 21,992
Net Receivables 14,791
Inventory 13,562
Other Current Assets 879
Total Current Assets  (as reported)54,309
Total Current Assets  (calculated)51,224
+/- 3,085
Long-term Assets
Property Plant Equipment 24,468
Intangible Assets 41
Other Assets 423
Long-term Assets  (as reported)24,932
Long-term Assets  (calculated)24,932
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities10,383
Long-term Liabilities291
Total Stockholder Equity68,567
Total Current Liabilities
Short Long Term Debt 1,291
Accounts payable 3,519
Other Current Liabilities 1,887
Total Current Liabilities  (as reported)10,383
Total Current Liabilities  (calculated)6,697
+/- 3,686
Long-term Liabilities
Other Liabilities 221
Long-term Liabilities  (as reported)291
Long-term Liabilities  (calculated)221
+/- 70
Total Stockholder Equity
Common Stock190,841
Retained Earnings -145,787
Other Stockholders Equity 23,513
Total Stockholder Equity (as reported)68,567
Total Stockholder Equity (calculated)68,567
+/-0
Other
Capital Stock190,841
Common Stock Shares Outstanding 276,522
Net Invested Capital 69,858
Net Tangible Assets 68,526
Net Working Capital 43,926



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
> Total Assets 
0
3,431
31,001
42,729
70,138
174,319
183,024
168,830
143,775
178,765
150,227
118,231
137,328
128,184
118,199
92,361
84,580
79,241
79,24184,58092,361118,199128,184137,328118,231150,227178,765143,775168,830183,024174,31970,13842,72931,0013,4310
   > Total Current Assets 
0
2,886
17,905
26,614
45,650
142,922
140,853
119,701
93,351
127,656
101,008
81,521
101,624
94,023
84,883
65,547
58,300
54,309
54,30958,30065,54784,88394,023101,62481,521101,008127,65693,351119,701140,853142,92245,65026,61417,9052,8860
       Cash And Cash Equivalents 
0
2,234
6,383
7,850
8,400
72,723
42,116
38,627
21,366
27,946
36,458
19,913
42,124
38,751
37,958
34,110
28,273
21,992
21,99228,27334,11037,95838,75142,12419,91336,45827,94621,36638,62742,11672,7238,4007,8506,3832,2340
       Short-term Investments 
0
16
442
400
200
200
200
0
0
0
0
0
0
0
0
0
0
0
00000000000200200200400442160
       Net Receivables 
0
109
1,734
6,427
13,884
25,361
40,786
27,540
24,836
37,593
29,822
34,137
32,265
36,891
29,152
16,918
14,860
14,791
14,79114,86016,91829,15236,89132,26534,13729,82237,59324,83627,54040,78625,36113,8846,4271,7341090
       Other Current Assets 
0
75
1,837
2,332
565
35
287
0
0
18,911
3,045
2,841
3,082
4,722
3,382
1,343
3,280
879
8793,2801,3433,3824,7223,0822,8413,04518,91100287355652,3321,837750
   > Long-term Assets 
0
0
0
0
24,488
31,397
42,171
49,129
50,424
51,109
49,219
36,710
35,704
34,161
33,316
26,814
26,280
24,932
24,93226,28026,81433,31634,16135,70436,71049,21951,10950,42449,12942,17131,39724,4880000
       Property Plant Equipment 
0
539
13,046
13,968
15,837
24,302
34,919
42,233
43,962
45,552
44,808
34,144
33,121
31,587
30,620
25,894
25,364
24,468
24,46825,36425,89430,62031,58733,12134,14444,80845,55243,96242,23334,91924,30215,83713,96813,0465390
       Long Term Investments 
0
6
50
81
157
189
189
189
191
191
191
191
191
191
191
0
0
0
000191191191191191191191189189189157815060
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
228
244
236
228
44
43
41
41434422823624422800000000000
       Other Assets 
0
0
0
2,066
8,494
6,906
7,063
6,707
6,271
5,366
4,220
2,147
2,148
2,147
2,277
876
873
423
4238738762,2772,1472,1482,1474,2205,3666,2716,7077,0636,9068,4942,066000
> Total Liabilities 
0
554
7,195
14,886
35,748
53,201
54,045
37,603
25,682
61,543
45,964
39,817
18,572
18,657
15,583
9,215
8,425
10,674
10,6748,4259,21515,58318,65718,57239,81745,96461,54325,68237,60354,04553,20135,74814,8867,1955540
   > Total Current Liabilities 
0
554
7,195
14,886
35,748
53,201
53,561
28,846
25,129
39,949
14,661
24,245
17,906
18,391
15,457
8,877
8,104
10,383
10,3838,1048,87715,45718,39117,90624,24514,66139,94925,12928,84653,56153,20135,74814,8867,1955540
       Short-term Debt 
0
0
0
0
0
0
6,000
1,459
0
0
0
0
0
0
0
0
0
0
00000000001,4596,000000000
       Short Long Term Debt 
0
0
0
0
6,000
6,000
6,000
1,459
9,351
1,257
7,382
7,375
3,102
1,732
1,968
0
0
1,291
1,291001,9681,7323,1027,3757,3821,2579,3511,4596,0006,0006,0000000
       Accounts payable 
0
329
4,990
8,094
20,356
43,605
41,636
19,057
11,697
5,646
2,116
5,549
2,646
6,628
5,976
2,991
2,795
3,519
3,5192,7952,9915,9766,6282,6465,5492,1165,64611,69719,05741,63643,60520,3568,0944,9903290
       Other Current Liabilities 
0
1
14
50
392
633
716
4,823
537
24,602
1,288
1,752
3,475
2,387
2,629
1,628
1,682
1,887
1,8871,6821,6282,6292,3873,4751,7521,28824,6025374,823716633392501410
   > Long-term Liabilities 
0
0
0
0
0
0
484
8,757
553
21,594
31,303
15,572
666
266
126
338
321
291
29132133812626666615,57231,30321,5945538,757484000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
6,933
7,655
4,811
518
174
20
235
234
221
221234235201745184,8117,6556,933000000000
> Total Stockholder Equity
2,873
2,881
23,579
27,649
34,259
121,019
128,981
131,547
118,665
117,981
105,386
78,414
118,756
109,527
102,616
83,146
76,155
68,567
68,56776,15583,146102,616109,527118,75678,414105,386117,981118,665131,547128,981121,01934,25927,64923,5792,8812,873
   Common Stock
0
3,063
27,460
34,065
38,474
120,602
121,062
122,807
124,166
125,517
127,619
138,508
186,434
188,609
188,603
190,550
190,634
190,841
190,841190,634190,550188,603188,609186,434138,508127,619125,517124,166122,807121,062120,60238,47434,06527,4603,0630
   Retained Earnings Total Equity000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000
   Capital Surplus 000000000000000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 
0
274
2,164
3,418
6,129
8,762
12,888
16,929
19,776
21,095
21,358
14,448
20,731
21,140
21,590
21,939
22,321
23,513
23,51322,32121,93921,59021,14020,73114,44821,35821,09519,77616,92912,8888,7626,1293,4182,1642740



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue21,711
Cost of Revenue-36,957
Gross Profit-15,246-15,246
 
Operating Income (+$)
Gross Profit-15,246
Operating Expense-64,720
Operating Income-43,009-79,966
 
Operating Expense (+$)
Research Development1,355
Selling General Administrative23,033
Selling And Marketing Expenses-
Operating Expense64,72024,388
 
Net Interest Income (+$)
Interest Income225
Interest Expense-10,506
Net Interest Income-10,281-10,281
 
Pretax Income (+$)
Operating Income-43,009
Net Interest Income-10,281
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-54,688-41,611
EBIT - interestExpense = -56,228
-54,688
-44,295
Interest Expense10,506
Earnings Before Interest and Taxes (ebit)-45,722-44,182
Earnings Before Interest and Taxes (ebitda)-38,549
 
After tax Income (+$)
Income Before Tax-54,688
Tax Provision-113
Net Income From Continuing Ops-54,801-54,801
Net Income-54,801
Net Income Applicable To Common Shares-54,801
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-73
Total Other Income/Expenses Net-1,39810,281
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
VAS.XETRA
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VAS.XETRA.

VAS.XETRA Daily Candlestick Chart
TL0.XETRA
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TL0.XETRA.

TL0.XETRA Daily Candlestick Chart
SZG.XETRA
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SZG.XETRA.

SZG.XETRA Daily Candlestick Chart
XAMB.XETRA
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of XAMB.XETRA.

XAMB.XETRA Daily Candlestick Chart
SOW.XETRA
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SOW.XETRA.

SOW.XETRA Daily Candlestick Chart
ALV.XETRA
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ALV.XETRA.

ALV.XETRA Daily Candlestick Chart
X010.XETRA
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of X010.XETRA.

X010.XETRA Daily Candlestick Chart
PUM.XETRA
now

I found you a STOCH Bullish Reversal Divergence on the daily chart of PUM.XETRA.

PUM.XETRA Daily Candlestick Chart
EXIC.XETRA
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of EXIC.XETRA.

EXIC.XETRA Daily Candlestick Chart
CSYX.XETRA
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of CSYX.XETRA.

CSYX.XETRA Daily Candlestick Chart
VGVF.XETRA
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VGVF.XETRA.

VGVF.XETRA Daily Candlestick Chart
V50D.XETRA
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of V50D.XETRA.

V50D.XETRA Daily Candlestick Chart
V50A.XETRA
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of V50A.XETRA.

V50A.XETRA Daily Candlestick Chart
UIMF.XETRA
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of UIMF.XETRA.

UIMF.XETRA Daily Candlestick Chart
10AH.XETRA
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of 10AH.XETRA.

10AH.XETRA Daily Candlestick Chart
TMV.XETRA
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TMV.XETRA.

TMV.XETRA Daily Candlestick Chart
SPPW.XETRA
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SPPW.XETRA.

SPPW.XETRA Daily Candlestick Chart
SC0J.XETRA
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SC0J.XETRA.

SC0J.XETRA Daily Candlestick Chart
SC01.XETRA
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SC01.XETRA.

SC01.XETRA Daily Candlestick Chart
QUED.XETRA
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of QUED.XETRA.

QUED.XETRA Daily Candlestick Chart
QDVS.XETRA
now

I found you a Oversold RSI (Relative Strength Index) on the daily chart of QDVS.XETRA.

QDVS.XETRA Daily Candlestick Chart
NEM.XETRA
2 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NEM.XETRA.

NEM.XETRA Daily Candlestick Chart
NDX1.XETRA
2 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of NDX1.XETRA.

NDX1.XETRA Daily Candlestick Chart
KCO.XETRA
2 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of KCO.XETRA.

KCO.XETRA Daily Candlestick Chart
MSED.XETRA
2 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of MSED.XETRA.

MSED.XETRA Daily Candlestick Chart